PMV Pharmaceuticals Inc (NASDAQ: PMVP) flaunted slowness of -6.43% at $1.60, before settling in for the price of $1.71 at the close. Taking a more long-term approach, PMVP posted a 52-week range of $1.17-$3.47.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 0.00%. Meanwhile, its Annual Earning per share during the time was -28.63%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 25.99%. This publicly-traded company’s shares outstanding now amounts to $51.45 million, simultaneously with a float of $43.54 million. The organization now has a market capitalization sitting at $82.43 million. At the time of writing, stock’s 50-day Moving Average stood at $1.5326, while the 200-day Moving Average is $1.6906.
PMV Pharmaceuticals Inc (PMVP) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the PMV Pharmaceuticals Inc industry. PMV Pharmaceuticals Inc’s current insider ownership accounts for 15.49%, in contrast to 73.58% institutional ownership. According to the most recent insider trade that took place on Sep 11 ’24, this organization’s Chief Development Officer sold 7,218 shares at the rate of 1.50, making the entire transaction reach 10,853 in total value, affecting insider ownership by 118,283. Preceding that transaction, on Sep 11 ’24, Company’s Chief Financial Officer sold 2,891 for 1.50, making the whole transaction’s value amount to 4,347. This particular insider is now the holder of 88,395 in total.
PMV Pharmaceuticals Inc (PMVP) Earnings and Revenue Records
PMV Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 25.99% and is forecasted to reach -1.55 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 23.10% through the next 5 years, which can be compared against the -28.63% growth it accomplished over the previous five years trading on the market.
PMV Pharmaceuticals Inc (NASDAQ: PMVP) Trading Performance Indicators
Let’s observe the current performance indicators for PMV Pharmaceuticals Inc (PMVP). It’s Quick Ratio in the last reported quarter now stands at 19.22. The Stock has managed to achieve an average true range (ATR) of 0.08.
In the same vein, PMVP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.97, a figure that is expected to reach -0.35 in the next quarter, and analysts are predicting that it will be -1.55 at the market close of one year from today.
Technical Analysis of PMV Pharmaceuticals Inc (PMVP)
Now, what If we examine the latest scores posted by [PMV Pharmaceuticals Inc, PMVP]. During the last 5-days, its volume was lower the volume of 0.42 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 65.33% While, its Average True Range was 0.0880.
Raw Stochastic average of PMV Pharmaceuticals Inc (PMVP) in the period of the previous 100 days is set at 44.44%, which indicates a major rise in contrast to 40.86% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 54.56% that was higher than 41.57% volatility it exhibited in the past 100-days period.
